This company listing is no longer active
Salud financiera de hoja de balance de TCR2 Therapeutics
Salud financiera controles de criterios 4/6
TCR2 Therapeutics has a total shareholder equity of $101.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $151.5M and $50.2M respectively.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
Ratio de cobertura de intereses | n/a |
Efectivo | US$110.31m |
Patrimonio | US$101.33m |
Total pasivo | US$50.18m |
Activos totales | US$151.51m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 2K7's short term assets ($140.5M) exceed its short term liabilities ($47.5M).
Pasivo a largo plazo: 2K7's short term assets ($140.5M) exceed its long term liabilities ($2.7M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 2K7 is debt free.
Reducción de la deuda: 2K7 has not had any debt for past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: 2K7 has less than a year of cash runway based on its current free cash flow.
Pronóstico de cash runway: 2K7 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 35.4% each year